S&P Capital IQ Focus Stock of the Week: Enterprise Products Partners LP

SP Capital IQ |

S&P Capital IQ Equity Analyst Tanjila Shafi has a 5-STARS  "Strong Buy" recommendation for Enterprise Products Partners LP. For more information, please visit:  www.marketscope.com

 

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
DITTF Daito Tr Constructn Co 96.50 0.00 0.00 0
EPD Enterprise Products Partners L.P. 27.63 0.21 0.77 2,632,402

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

Cloudera

Cloudera offers enterprises a new data platform built on the Apache Hadoop open-source software package. Hadoop is a data-management platform that can consolidate data in a single repository for comprehensive…

Lyft

Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…